Clinical Trial Update: Randomized Study to Evaluate the Efficacy of Fluvastatin on Inflammatory Markers in Patients With Aortic Stenosis. [Phase 4]

View source ↗

Summary

Phase 4 randomized trial investigating whether fluvastatin affects inflammatory markers in patients with aortic valve stenosis; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Stenosis

Drugs mentioned

• Fluvastatin (fluvastatin)

Snippet

Sponsor: AORTICA Group | Conditions: Aortic Valve Stenosis | Phase 4 | Status: TERMINATED